{"id":24075,"date":"2022-01-12T19:56:37","date_gmt":"2022-01-12T16:56:37","guid":{"rendered":"https:\/\/zdmaa.com\/precision-medicine-is-redefining-what-makes-a-cancer-rare\/"},"modified":"2022-01-13T00:15:55","modified_gmt":"2022-01-12T21:15:55","slug":"precision-medicine-is-redefining-what-makes-a-cancer-rare","status":"publish","type":"post","link":"https:\/\/zdmaa.com\/fr\/precision-medicine-is-redefining-what-makes-a-cancer-rare\/","title":{"rendered":"La m\u00e9decine de pr\u00e9cision red\u00e9finit ce qui rend le cancer rare"},"content":{"rendered":"<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"><span class=\"\" style=\"vertical-align: inherit;\">La m\u00e9decine de pr\u00e9cision red\u00e9finit ce qui rend le cancer rare<\/span><\/span><\/span><\/span><\/p>\n<div>\n<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Avoir un cancer est d\u00e9j\u00e0 assez difficile, mais le diagnostic d&rsquo;un cancer rare s&rsquo;accompagne souvent de difficult\u00e9s suppl\u00e9mentaires. <\/span><span style=\"vertical-align: inherit;\">De nombreux cancers rares sont difficiles \u00e0 identifier, ce qui peut entra\u00eener un diagnostic tardif ou une perte de diagnostic. <\/span><span style=\"vertical-align: inherit;\">Il est \u00e9galement difficile de trouver des m\u00e9decins exp\u00e9riment\u00e9s dans le traitement de ces maladies, et peu d&rsquo;informations sont g\u00e9n\u00e9ralement disponibles \u00e0 leur sujet. <\/span><span style=\"vertical-align: inherit;\">Parce qu&rsquo;ils affectent beaucoup moins de patients, par d\u00e9finition, relativement peu d&rsquo;essais cliniques consacrent du temps et des ressources au d\u00e9veloppement de nouveaux traitements pour les cancers rares, ce qui signifie souvent moins d&rsquo;options pour les traiter.<\/span><\/span><\/p>\n<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Mais dans un nombre croissant de cas, l&rsquo;\u00e8re de la m\u00e9decine de pr\u00e9cision a chang\u00e9 les perceptions sur les cancers rares et courants. <\/span><span style=\"vertical-align: inherit;\">La recherche a montr\u00e9 que certains cancers qui ont longtemps \u00e9t\u00e9 consid\u00e9r\u00e9s comme communs ne sont qu&rsquo;un groupe de sous-types rares qui partagent la m\u00eame origine. <\/span><span style=\"vertical-align: inherit;\">Les progr\u00e8s de l&rsquo;immunoth\u00e9rapie ont \u00e9galement conduit \u00e0 de nouveaux traitements pour certains types de cancers rares qui \u00e9taient autrefois difficiles \u00e0 traiter. <\/span><span style=\"vertical-align: inherit;\">Des tests g\u00e9nomiques avanc\u00e9s ont r\u00e9v\u00e9l\u00e9 des caract\u00e9ristiques mol\u00e9culaires dans certains cancers rares qui peuvent \u00eatre trait\u00e9s avec des m\u00e9dicaments pr\u00e9c\u00e9demment d\u00e9velopp\u00e9s pour des formes plus courantes de la maladie. <\/span><span style=\"vertical-align: inherit;\">\u00ab\u00a0La <\/span><span style=\"vertical-align: inherit;\">d\u00e9finition des <\/span><span style=\"vertical-align: inherit;\">cancers rares a chang\u00e9 au fil du temps, en raison du <\/span><span style=\"vertical-align: inherit;\">r\u00f4le des <\/span><span style=\"vertical-align: inherit;\">tests g\u00e9n\u00e9tiques et de la <\/span><span style=\"vertical-align: inherit;\">preuve que diff\u00e9rents sous-types fournissent des informations cliniquement utiles affectant les r\u00e9sultats du <\/span><span style=\"vertical-align: inherit;\">traitement\u00a0\u00bb, comme le dit Murray Markman, chef du <\/span><span style=\"vertical-align: inherit;\">d\u00e9partement de <\/span><span style=\"vertical-align: inherit;\">m\u00e9decine et des sciences. les centres am\u00e9ricains de traitement du cancer <\/span><\/span><sup><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">\u00ae<\/span><\/span><\/sup><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"> (CTCA).<\/span><\/span><\/p>\n<h2><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Faits rares sur le cancer<\/span><\/span><\/h2>\n<ul>\n<li><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Les cancers rares repr\u00e9sentent environ 20 pour cent de tous les diagnostics de cancer chez les adultes.<\/span><\/span><\/li>\n<li><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">En Europe, le cancer rare est d\u00e9fini comme une maladie dans laquelle 6 cas ou moins sont diagnostiqu\u00e9s pour 100 000 personnes par an, moins de la moiti\u00e9 du nombre (15) utilis\u00e9 aux \u00c9tats-Unis.<\/span><\/span><\/li>\n<li><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">La plupart des cancers rares sont diagnostiqu\u00e9s chez les enfants, les adolescents et les jeunes adultes. <\/span><span style=\"vertical-align: inherit;\">Les cancers rares repr\u00e9sentent 71% des diagnostics chez les patients de moins de 20 ans et 39% chez les patients de 20 \u00e0 39 ans.<\/span><\/span><\/li>\n<\/ul>\n<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">De l&rsquo;ad\u00e9nome (une forme rare de cancer des os) \u00e0 la m\u00e9gaglobuline de Waldenstrom (un type de lymphome non hodgkinien), plus de 500 types de cancers rares ont \u00e9t\u00e9 document\u00e9s, selon le National Cancer Institute (NCI). <\/span><span style=\"vertical-align: inherit;\">Les cancers rares ne sont pas seulement ceux qui ne peuvent pas \u00eatre prononc\u00e9s et qui se trouvent dans certaines cellules ou dans des parties plus sombres du corps. <\/span><span style=\"vertical-align: inherit;\">Ils comprennent \u00e9galement le cancer de l&rsquo;estomac, de l&rsquo;\u0153sophage, des os, du vagin, du p\u00e9nis et de la v\u00e9sicule biliaire.<\/span><\/span><\/p>\n<table class=\"tableizer-table\">\n<thead>\n<tr class=\"tableizer-firstrow\">\n<th><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Choisissez des cancers rares<\/span><\/span><\/th>\n<th><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">nouveaux cas <\/span><\/span><br \/>\n<span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">pour 100 000<\/span><\/span><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">trach\u00e9e<\/span><\/span><\/td>\n<td><center><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">0,2<\/span><\/span><\/center><\/td>\n<\/tr>\n<tr>\n<td><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Sarcome de Kabozi<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/td>\n<td><center><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">0,5<\/span><\/span><\/center><\/td>\n<\/tr>\n<tr>\n<td><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Abdomen (p\u00e9riton\u00e9al <\/span><\/span><br \/>\n<span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">et r\u00e9trop\u00e9riton\u00e9al)<\/span><\/span><\/td>\n<td><center><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">0,7<\/span><\/span><\/center><\/td>\n<\/tr>\n<tr>\n<td><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">uret\u00e8re<\/span><\/span><\/td>\n<td><center><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">0,8<\/span><\/span><\/center><\/td>\n<\/tr>\n<tr>\n<td><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">l\u00e8vre<\/span><\/span><\/td>\n<td><center><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">0,8<\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/span><\/center><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Parce que ces cancers sont si rares, il est souvent difficile de trouver des informations sur la fa\u00e7on de les identifier, de les stadifier ou de les traiter. <\/span><span style=\"vertical-align: inherit;\">\u00ab Dans les milieux o\u00f9 l&rsquo;exp\u00e9rience dans le traitement des cancers est limit\u00e9e, la gestion des cancers rares est un d\u00e9fi particulier \u00bb, explique le Dr Markman. <\/span><span style=\"vertical-align: inherit;\">\u00ab\u00a0Un m\u00e9decin ne peut voir qu&rsquo;un cas toutes les quelques ann\u00e9es, voire moins. Et le manque d&rsquo;essais cliniques pour les types rares de cancer rend la situation encore plus difficile.\u00a0\u00bb<\/span><\/span><\/p>\n<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">En approfondissant leur compr\u00e9hension du mod\u00e8le de cancer sp\u00e9cifique, les scientifiques et les oncologues ont d\u00e9couvert que certains des cancers dits courants peuvent ne pas \u00eatre courants du tout. <\/span><span style=\"vertical-align: inherit;\">L&rsquo;auteur d&rsquo;un article de 2016 sur les cancers rares a \u00e9crit dans <\/span><\/span><em><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Lancet Oncology,<\/span><\/span><\/em><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"> ajoutant que \u00ab\u00a0rare est le nouveau lieu commun de l&rsquo;\u00e8re post-g\u00e9nomique\u00a0\u00bb. <\/span><span style=\"vertical-align: inherit;\">Par exemple, le cancer de la peau est le cinqui\u00e8me cancer le plus fr\u00e9quemment diagnostiqu\u00e9 aux \u00c9tats-Unis, avec plus de 90 000 nouveaux cas par an. <\/span><span style=\"vertical-align: inherit;\">Mais les scientifiques ont divis\u00e9 le cancer de la peau en plusieurs sous-types, chacun avec des mutations uniques dans son ADN. <\/span><span style=\"vertical-align: inherit;\">Le m\u00e9lanome \u00ab\u00a0est un groupe de cancers rares, chacun avec une biologie unique qui a des implications diff\u00e9rentes pour le traitement, et est un mod\u00e8le de plus en plus courant en oncologie\u00a0\u00bb, ont \u00e9crit les chercheurs. <\/span><span style=\"vertical-align: inherit;\">Chacun de ces sous-types est consid\u00e9r\u00e9 comme un cancer rare, selon les directives du National Cancer Institute.<\/span><\/span><\/p>\n<table class=\"tableizer-table\">\n<thead>\n<tr class=\"tableizer-firstrow\">\n<th><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Cancers les plus courants<\/span><\/span><\/th>\n<th><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">nouveaux cas <\/span><\/span><br \/>\n<span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">pour 100 000<\/span><\/span><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Cancer du sein chez la femme<\/span><\/span><\/td>\n<td><center><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">126<\/span><\/span><\/center><\/td>\n<\/tr>\n<tr>\n<td><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">prostate<\/span><\/span><\/td>\n<td><center><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">113<\/span><\/span><\/center><\/td>\n<\/tr>\n<tr>\n<td><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Poumon et bronches<\/span><\/span><\/td>\n<td><center><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">55<\/span><\/span><\/center><\/td>\n<\/tr>\n<tr>\n<td><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">c\u00f4lon et rectum<\/span><\/span><\/td>\n<td><center><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">39<\/span><\/span><\/center><\/td>\n<\/tr>\n<tr>\n<td><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">cancer de la peau<\/span><\/span><\/td>\n<td><center><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">29<\/span><\/span><\/center><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Les tests g\u00e9n\u00e9tiques pour les cancers rares peuvent \u00e9galement d\u00e9tecter des mutations courantes trouv\u00e9es dans une vari\u00e9t\u00e9 de cancers, ce qui pourrait conduire \u00e0 de nouveaux traitements. <\/span><span style=\"vertical-align: inherit;\">\u00ab\u00a0Nous recherchons peut-\u00eatre des traitements contre le cancer rare bas\u00e9s sur une analyse g\u00e9n\u00e9tique qui a \u00e9t\u00e9 initialement effectu\u00e9e sur de nombreux cancers courants ou o\u00f9 les mutations apparaissent plus fr\u00e9quemment\u00a0\u00bb, explique le Dr Markman. <\/span><span style=\"vertical-align: inherit;\">\u00ab\u00a0Par exemple, une mutation HER-2 est \u00e9troitement li\u00e9e au cancer du sein, mais la pr\u00e9sence de cette anomalie peut aider \u00e0 d\u00e9terminer une approche th\u00e9rapeutique efficace pour le cancer o\u00f9 la th\u00e9rapie anti-HER-2 n&rsquo;est pas naturellement disponible. Envisagez un traitement standard. \u00a0\u00bb Chercheurs \u00e9tudient un m\u00e9dicament de th\u00e9rapie cibl\u00e9e. trastuzumab (Herceptin <\/span><\/span><sup><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">\u00ae<\/span><\/span><\/sup><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"> ), qui est <\/span><span style=\"vertical-align: inherit;\">souvent prescrit pour le <\/span><span style=\"vertical-align: inherit;\">traitement du <\/span><span style=\"vertical-align: inherit;\">cancer du sein HER2 &#8211; <\/span><span style=\"vertical-align: inherit;\">positif, comme un <\/span><span style=\"vertical-align: inherit;\">traitement potentiel du cancer du <\/span><span style=\"vertical-align: inherit;\">canal salivaire et du <\/span><span style=\"vertical-align: inherit;\">s\u00e9rum de cancer de l&rsquo; <\/span><span style=\"vertical-align: inherit;\">ut\u00e9rus et des <\/span><span style=\"vertical-align: inherit;\">cancers rares et agressifs , <\/span><span style=\"vertical-align: inherit;\">qui peut contenir mutations HER2 positives.<\/span><\/span><\/p>\n<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Ces nouvelles d\u00e9couvertes qui ont marqu\u00e9 l&rsquo;\u00e8re de la m\u00e9decine de pr\u00e9cision ont permis de d\u00e9boucher sur de nouveaux traitements et des traitements potentiels pour les cancers rares. <\/span><span style=\"vertical-align: inherit;\">En 2017, des m\u00e9dicaments d&rsquo;immunoth\u00e9rapie connus sous le nom d&rsquo;inhibiteurs de point de contr\u00f4le ont \u00e9t\u00e9 approuv\u00e9s pour traiter le carcinome \u00e0 cellules de Merkel, une forme extr\u00eamement rare de cancer de la peau, et le lymphome de Hodgkin, un cancer du sang rare. <\/span><span style=\"vertical-align: inherit;\">L&rsquo;immunoth\u00e9rapie est \u00e9galement \u00e0 l&rsquo;\u00e9tude comme traitement potentiel pour d&rsquo;autres types rares de cancer, tels que le carcinome thymique et le m\u00e9soth\u00e9liome.<\/span><\/span><\/p>\n<h2><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">D\u00e9fi cancer rare<\/span><\/span><\/h2>\n<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Cependant, les cancers consid\u00e9r\u00e9s comme rares posent encore des d\u00e9fis aux cliniciens et aux patients. <\/span><span style=\"vertical-align: inherit;\">Selon une \u00e9tude de 2017 de l&rsquo;American Cancer Society :<\/span><\/span><\/p>\n<ul>\n<li><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">59 % des cancers rares sont diagnostiqu\u00e9s \u00e0 un stade avanc\u00e9, contre 45 % des cancers courants.<\/span><\/span><\/li>\n<li><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Le taux de survie \u00e0 cinq ans pour les hommes atteints de cancers rares est de 55 pour cent, contre 75 pour cent pour les cancers courants.<\/span><\/span><\/li>\n<li><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Le taux de survie \u00e0 cinq ans pour les femmes atteintes de cancers rares est de 60 pour cent, contre 74 pour cent pour les cancers courants.<\/span><\/span><\/li>\n<\/ul>\n<p>\u0648\u0642\u0627\u0644\u062a \u0645\u0624\u0644\u0641\u0629 \u0627\u0644\u062f\u0631\u0627\u0633\u0629 \u0643\u0627\u0631\u0648\u0644 \u062f\u064a\u0633\u0627\u0646\u062a\u0633 \u060c MPH: \u00ab\u00a0\u0643\u0627\u0646 \u0627\u0644\u0627\u0643\u062a\u0634\u0627\u0641 \u0627\u0644\u0623\u0643\u062b\u0631 \u0623\u0647\u0645\u064a\u0629 \u0647\u0648 \u0645\u0639\u0631\u0641\u0629 \u0623\u0646 \u0627\u0644\u0633\u0631\u0637\u0627\u0646\u0627\u062a \u0627\u0644\u0646\u0627\u062f\u0631\u0629 \u0628\u0634\u0643\u0644 \u062c\u0645\u0627\u0639\u064a \u0644\u0627 \u064a\u0632\u0627\u0644 \u0645\u0646 \u0627\u0644\u0645\u062d\u062a\u0645\u0644 \u0623\u0646 \u064a\u062a\u0645 \u062a\u0634\u062e\u064a\u0635\u0647\u0627 \u0641\u064a \u0645\u0631\u0627\u062d\u0644 \u0644\u0627\u062d\u0642\u0629 \u0648\u0623\u0646 \u0645\u0639\u062f\u0644 \u0627\u0644\u0628\u0642\u0627\u0621 \u0639\u0644\u0649 \u0642\u064a\u062f \u0627\u0644\u062d\u064a\u0627\u0629 \u0645\u0646\u062e\u0641\u0636 \u0628\u0634\u0643\u0644 \u0639\u0627\u0645\u00a0\u00bb. <em>\u062f\u0648\u0627\u0621<\/em> \u0645\u062c\u0644\u0629. \u0642\u062f \u062a\u0643\u0648\u0646 \u0645\u0648\u0627\u062c\u0647\u0629 \u0645\u062b\u0644 \u0647\u0630\u0647 \u0627\u0644\u0646\u0633\u0628 \u0627\u0644\u0647\u0627\u0626\u0644\u0629 \u0623\u0645\u0631\u064b\u0627 \u0645\u062f\u0645\u0631\u064b\u0627 \u0644\u0644\u0645\u0631\u0636\u0649. \u0644\u0643\u0646 \u0633\u062a\u064a\u0641\u0646 \u0644\u064a\u0646\u0634 \u060c MD \u060c \u0637\u0628\u064a\u0628 \u0627\u0644\u0625\u062f\u062e\u0627\u0644 \u0648\u0627\u0644\u0631\u0639\u0627\u064a\u0629 \u0627\u0644\u0623\u0648\u0644\u064a\u0629 \u0641\u064a \u0645\u0633\u062a\u0634\u0641\u0649 \u0641\u064a\u0646\u064a\u0643\u0633 \u060c \u064a\u0634\u062c\u0639 \u0627\u0644\u0645\u0631\u0636\u0649 \u0639\u0644\u0649 \u0627\u0644\u062a\u062d\u0643\u0645 \u0641\u064a \u062a\u0634\u062e\u064a\u0635\u0627\u062a\u0647\u0645 \u0648\u0645\u0639\u0631\u0641\u0629 \u0643\u0644 \u0645\u0627 \u0641\u064a \u0648\u0633\u0639\u0647\u0645 \u0639\u0646 \u0627\u0644\u0633\u0631\u0637\u0627\u0646. \u064a\u0642\u0648\u0644 \u0627\u0644\u062f\u0643\u062a\u0648\u0631 \u0644\u064a\u0646\u0634: \u00ab\u00a0\u0641\u064a \u0643\u062b\u064a\u0631 \u0645\u0646 \u0627\u0644\u0623\u062d\u064a\u0627\u0646 \u060c \u0633\u0648\u0627\u0621 \u0643\u0627\u0646 \u0633\u0631\u0637\u0627\u0646\u064b\u0627 \u0634\u0627\u0626\u0639\u064b\u0627 \u0623\u0648 \u0646\u0627\u062f\u0631\u064b\u0627 \u0628\u0627\u0644\u0641\u0639\u0644 \u060c \u0644\u0627 \u064a\u0641\u0647\u0645\u0647 \u0627\u0644\u0643\u062b\u064a\u0631 \u0645\u0646 \u0627\u0644\u0645\u0631\u0636\u0649 \u062d\u0642\u064b\u0627\u00a0\u00bb. \u0644\u0642\u062f \u0642\u064a\u0644 \u0644\u0647\u0646 \u0625\u0646\u0647\u0646 \u0645\u0635\u0627\u0628\u0627\u062a \u0628\u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u062b\u062f\u064a. \u062d\u0633\u0646\u064b\u0627 \u060c \u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u062b\u062f\u064a \u0644\u0647 \u0627\u0644\u0639\u062f\u064a\u062f \u0645\u0646 \u0627\u0644\u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0645\u062e\u062a\u0644\u0641\u0629. \u0642\u064a\u0644 \u0644\u0647\u0645 \u0625\u0646\u0647\u0645 \u0645\u0635\u0627\u0628\u0648\u0646 \u0628\u0633\u0631\u0637\u0627\u0646 \u0627\u0644\u0631\u0626\u0629. \u0647\u0646\u0627\u0643 \u0627\u0644\u0639\u062f\u064a\u062f \u0645\u0646 \u0627\u0644\u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0645\u062e\u062a\u0644\u0641\u0629. \u0644\u0630\u0627 \u0641\u0625\u0646 \u0623\u0648\u0644 \u0648\u0623\u0647\u0645 \u0634\u064a\u0621 \u0647\u0648 \u0645\u0633\u0627\u0639\u062f\u0629 \u0627\u0644\u0645\u0631\u064a\u0636 \u0639\u0644\u0649 \u0641\u0647\u0645 \u0623\u0633\u0628\u0627\u0628 \u0645\u0631\u0636\u0647 \u00ab\u00a0.<\/p>\n<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Alors que les scientifiques et les chercheurs se penchent sur la g\u00e9nomique de chaque cancer, ils d\u00e9couvrent que chaque cancer, comme chaque patient, poss\u00e8de des caract\u00e9ristiques uniques qui n\u00e9cessitent souvent des traitements individuels. <\/span><span style=\"vertical-align: inherit;\">Le Dr Lynch dit qu&rsquo;il est important d&rsquo;\u00e9duquer les patients sur ce qui fait fonctionner leur cancer en particulier, m\u00eame s&rsquo;il est class\u00e9 comme courant ou rare. <\/span><span style=\"vertical-align: inherit;\">\u00ab\u00a0En approfondissant ce diagnostic et en aidant les patients \u00e0 en savoir plus sur les aspects mol\u00e9culaires uniques de leur tumeur, ils les aideront \u00e0 mieux comprendre \u00e0 quoi ils ont affaire et quelles questions poser\u00a0\u00bb, dit-il.<\/span><\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>La m\u00e9decine de pr\u00e9cision red\u00e9finit ce qui rend le cancer rare Avoir un cancer est d\u00e9j\u00e0 assez difficile, mais le diagnostic d&rsquo;un cancer rare s&rsquo;accompagne souvent de difficult\u00e9s suppl\u00e9mentaires. De nombreux cancers rares sont difficiles \u00e0 identifier, ce qui peut entra\u00eener un diagnostic tardif ou une perte de diagnostic. Il est \u00e9galement difficile de trouver &hellip;<\/p>\n","protected":false},"author":1,"featured_media":23466,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17],"tags":[],"class_list":["post-24075","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-non-classifiee"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>La m\u00e9decine de pr\u00e9cision red\u00e9finit ce qui rend le cancer rare - zdmaa<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/zdmaa.com\/fr\/precision-medicine-is-redefining-what-makes-a-cancer-rare\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La m\u00e9decine de pr\u00e9cision red\u00e9finit ce qui rend le cancer rare - zdmaa\" \/>\n<meta property=\"og:description\" content=\"La m\u00e9decine de pr\u00e9cision red\u00e9finit ce qui rend le cancer rare Avoir un cancer est d\u00e9j\u00e0 assez difficile, mais le diagnostic d&rsquo;un cancer rare s&rsquo;accompagne souvent de difficult\u00e9s suppl\u00e9mentaires. De nombreux cancers rares sont difficiles \u00e0 identifier, ce qui peut entra\u00eener un diagnostic tardif ou une perte de diagnostic. Il est \u00e9galement difficile de trouver &hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/zdmaa.com\/fr\/precision-medicine-is-redefining-what-makes-a-cancer-rare\/\" \/>\n<meta property=\"og:site_name\" content=\"zdmaa\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-12T16:56:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-01-12T21:15:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/doctor-g898d516db_640.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"427\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/zdmaa.com\/fr\/precision-medicine-is-redefining-what-makes-a-cancer-rare\/\",\"url\":\"https:\/\/zdmaa.com\/fr\/precision-medicine-is-redefining-what-makes-a-cancer-rare\/\",\"name\":\"La m\u00e9decine de pr\u00e9cision red\u00e9finit ce qui rend le cancer rare - zdmaa\",\"isPartOf\":{\"@id\":\"https:\/\/zdmaa.com\/fr\/ro\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/zdmaa.com\/fr\/precision-medicine-is-redefining-what-makes-a-cancer-rare\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/zdmaa.com\/fr\/precision-medicine-is-redefining-what-makes-a-cancer-rare\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/doctor-g898d516db_640.jpg\",\"datePublished\":\"2022-01-12T16:56:37+00:00\",\"dateModified\":\"2022-01-12T21:15:55+00:00\",\"author\":{\"@id\":\"https:\/\/zdmaa.com\/fr\/ro\/#\/schema\/person\/8aad4cf5d562d4ca835487f6149853e3\"},\"breadcrumb\":{\"@id\":\"https:\/\/zdmaa.com\/fr\/precision-medicine-is-redefining-what-makes-a-cancer-rare\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/zdmaa.com\/fr\/precision-medicine-is-redefining-what-makes-a-cancer-rare\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/zdmaa.com\/fr\/precision-medicine-is-redefining-what-makes-a-cancer-rare\/#primaryimage\",\"url\":\"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/doctor-g898d516db_640.jpg\",\"contentUrl\":\"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/doctor-g898d516db_640.jpg\",\"width\":640,\"height\":427,\"caption\":\"Precision medicine is redefining what makes a cancer rare\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/zdmaa.com\/fr\/precision-medicine-is-redefining-what-makes-a-cancer-rare\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629\",\"item\":\"https:\/\/zdmaa.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La m\u00e9decine de pr\u00e9cision red\u00e9finit ce qui rend le cancer rare\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/zdmaa.com\/fr\/ro\/#website\",\"url\":\"https:\/\/zdmaa.com\/fr\/ro\/\",\"name\":\"zdmaa\",\"description\":\"zdmaa\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/zdmaa.com\/fr\/ro\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/zdmaa.com\/fr\/ro\/#\/schema\/person\/8aad4cf5d562d4ca835487f6149853e3\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/zdmaa.com\/fr\/ro\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/zdmaa.com\/wp-content\/litespeed\/avatar\/dff6d89ac221c1aaf9366bf5b4cd32de.jpg?ver=1775954700\",\"contentUrl\":\"https:\/\/zdmaa.com\/wp-content\/litespeed\/avatar\/dff6d89ac221c1aaf9366bf5b4cd32de.jpg?ver=1775954700\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/zdmaa.com\"],\"url\":\"https:\/\/zdmaa.com\/fr\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La m\u00e9decine de pr\u00e9cision red\u00e9finit ce qui rend le cancer rare - zdmaa","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/zdmaa.com\/fr\/precision-medicine-is-redefining-what-makes-a-cancer-rare\/","og_locale":"fr_FR","og_type":"article","og_title":"La m\u00e9decine de pr\u00e9cision red\u00e9finit ce qui rend le cancer rare - zdmaa","og_description":"La m\u00e9decine de pr\u00e9cision red\u00e9finit ce qui rend le cancer rare Avoir un cancer est d\u00e9j\u00e0 assez difficile, mais le diagnostic d&rsquo;un cancer rare s&rsquo;accompagne souvent de difficult\u00e9s suppl\u00e9mentaires. De nombreux cancers rares sont difficiles \u00e0 identifier, ce qui peut entra\u00eener un diagnostic tardif ou une perte de diagnostic. Il est \u00e9galement difficile de trouver &hellip;","og_url":"https:\/\/zdmaa.com\/fr\/precision-medicine-is-redefining-what-makes-a-cancer-rare\/","og_site_name":"zdmaa","article_published_time":"2022-01-12T16:56:37+00:00","article_modified_time":"2022-01-12T21:15:55+00:00","og_image":[{"width":640,"height":427,"url":"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/doctor-g898d516db_640.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"admin","Dur\u00e9e de lecture estim\u00e9e":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/zdmaa.com\/fr\/precision-medicine-is-redefining-what-makes-a-cancer-rare\/","url":"https:\/\/zdmaa.com\/fr\/precision-medicine-is-redefining-what-makes-a-cancer-rare\/","name":"La m\u00e9decine de pr\u00e9cision red\u00e9finit ce qui rend le cancer rare - zdmaa","isPartOf":{"@id":"https:\/\/zdmaa.com\/fr\/ro\/#website"},"primaryImageOfPage":{"@id":"https:\/\/zdmaa.com\/fr\/precision-medicine-is-redefining-what-makes-a-cancer-rare\/#primaryimage"},"image":{"@id":"https:\/\/zdmaa.com\/fr\/precision-medicine-is-redefining-what-makes-a-cancer-rare\/#primaryimage"},"thumbnailUrl":"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/doctor-g898d516db_640.jpg","datePublished":"2022-01-12T16:56:37+00:00","dateModified":"2022-01-12T21:15:55+00:00","author":{"@id":"https:\/\/zdmaa.com\/fr\/ro\/#\/schema\/person\/8aad4cf5d562d4ca835487f6149853e3"},"breadcrumb":{"@id":"https:\/\/zdmaa.com\/fr\/precision-medicine-is-redefining-what-makes-a-cancer-rare\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/zdmaa.com\/fr\/precision-medicine-is-redefining-what-makes-a-cancer-rare\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/zdmaa.com\/fr\/precision-medicine-is-redefining-what-makes-a-cancer-rare\/#primaryimage","url":"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/doctor-g898d516db_640.jpg","contentUrl":"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/doctor-g898d516db_640.jpg","width":640,"height":427,"caption":"Precision medicine is redefining what makes a cancer rare"},{"@type":"BreadcrumbList","@id":"https:\/\/zdmaa.com\/fr\/precision-medicine-is-redefining-what-makes-a-cancer-rare\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629","item":"https:\/\/zdmaa.com\/fr\/"},{"@type":"ListItem","position":2,"name":"La m\u00e9decine de pr\u00e9cision red\u00e9finit ce qui rend le cancer rare"}]},{"@type":"WebSite","@id":"https:\/\/zdmaa.com\/fr\/ro\/#website","url":"https:\/\/zdmaa.com\/fr\/ro\/","name":"zdmaa","description":"zdmaa","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/zdmaa.com\/fr\/ro\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/zdmaa.com\/fr\/ro\/#\/schema\/person\/8aad4cf5d562d4ca835487f6149853e3","name":"admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/zdmaa.com\/fr\/ro\/#\/schema\/person\/image\/","url":"https:\/\/zdmaa.com\/wp-content\/litespeed\/avatar\/dff6d89ac221c1aaf9366bf5b4cd32de.jpg?ver=1775954700","contentUrl":"https:\/\/zdmaa.com\/wp-content\/litespeed\/avatar\/dff6d89ac221c1aaf9366bf5b4cd32de.jpg?ver=1775954700","caption":"admin"},"sameAs":["https:\/\/zdmaa.com"],"url":"https:\/\/zdmaa.com\/fr\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/zdmaa.com\/fr\/wp-json\/wp\/v2\/posts\/24075","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zdmaa.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zdmaa.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/zdmaa.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/zdmaa.com\/fr\/wp-json\/wp\/v2\/comments?post=24075"}],"version-history":[{"count":1,"href":"https:\/\/zdmaa.com\/fr\/wp-json\/wp\/v2\/posts\/24075\/revisions"}],"predecessor-version":[{"id":24105,"href":"https:\/\/zdmaa.com\/fr\/wp-json\/wp\/v2\/posts\/24075\/revisions\/24105"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/zdmaa.com\/fr\/wp-json\/wp\/v2\/media\/23466"}],"wp:attachment":[{"href":"https:\/\/zdmaa.com\/fr\/wp-json\/wp\/v2\/media?parent=24075"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zdmaa.com\/fr\/wp-json\/wp\/v2\/categories?post=24075"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zdmaa.com\/fr\/wp-json\/wp\/v2\/tags?post=24075"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}